NSEUpdates28 Sept 2026 · 28 Sept 2026, 08:09 pm
Updates
Sun Pharmaceutical Industries Limited · SUNPHARMA
✦ AI Summary
Sun Pharmaceutical Industries Limited has informed the Exchange regarding the completion and result of the Postal Ballot dated 25 August 2026, where the resolution was approved by the shareholders by the requisite majority.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Completion and Result of Postal Ballot dated 25 August 2026'.
Attachments (1)
📄pdf
Download →
SUNSEC_28092026200828_SEIntimationforVR.pdf
View document text
Sun Pharmaceutical Industries Limited
Sun House, Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai – 400 063, Maharashtra, INDIA.
Tel. : (91-22) 4324 4324
Fax : (91-22) 4324 4343
Website: www.sunpharma.com
Email: secretarial@sunpharma.com
CIN: L24230GJ1993PLC019050
28 September 2026
National Stock Exchange of India Limited BSE Limited
Scrip Symbol: SUNPHARMA Scrip Code: 524715
Completion and Result of Postal Ballot dated 25 August 2026
This is to inform that the Postal Ballot process initiated pursuant to the Notice dated 25 August 2026,
wherein the remote e-voting period commenced on 28 August 2026, has been completed on 26 September
2026, and the resolution as set out in the Notice, has been duly approved by the shareholders by the
requisite majority.
The details of the voting results have been submitted to the stock exchanges, and the Scrutinizer’s Report
is made available on the Company’s website at www.sunpharma.com.
For Sun Pharmaceutical Industries Limited
(Anoop Deshpande)
Company Secretary and Compliance Officer
ICSI Membership No.: A23983
Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.
Reaching People. Touching Lives.